Steroid Tapering Protocol in IBD

Initial Dosing Strategy

The American Gastroenterological Association recommends starting with prednisolone 40 mg daily for mild to moderate ulcerative colitis, achieving 77% remission within 2 weeks 1, 2
Doses below 15 mg daily are ineffective for active disease, according to the European Crohn's and Colitis Organisation 1, 2
Combining oral and rectal steroids may be considered for superior efficacy compared to either alone, as suggested by the American College of Gastroenterology 1, 2
For Crohn's disease, the European Crohn's and Colitis Organisation recommends using prednisolone 0.5-0.75 mg/kg/day with tapering over 17 weeks, achieving 60% remission 1, 2
Alternatively, 1 mg/kg/day achieves 83% remission over 18 weeks, according to the American Gastroenterological Association 1, 2
For ileocecal disease specifically, consider budesonide 9 mg daily for 8 weeks as a first-line alternative with reduced systemic toxicity, as recommended by the National Institute for Health and Care Excellence 3, 4, 5

Begin tapering once symptoms improve to grade ≤1, as suggested by the Journal for ImmunoTherapy of Cancer 6
Implement a 4-6 week steroid taper for grade 2-3 adverse events or disease activity, according to the American College of Gastroenterology 6
Rapid tapering of 10 mg per week can be considered when minimizing steroid exposure is critical, though this must be balanced against risk of extending overall steroid exposure if tapering occurs too quickly, as recommended by the European Crohn's and Colitis Organisation 7, 3, 4, 5
Too rapid reduction is associated with early relapse, according to the American Gastroenterological Association 1, 2

Monitor for disease relapse, particularly as dose decreases below 15 mg, as suggested by the European Crohn's and Colitis Organisation 1, 2
Identify steroid dependency early: patients requiring ≥2 corticosteroid courses within a calendar year, those who relapse as dose reduces below 15 mg, or those who relapse within 6 weeks of stopping steroids, according to the American College of Gastroenterology 1, 2
These patients require steroid-sparing agents rather than repeated steroid courses, as recommended by the National Institute for Health and Care Excellence 1, 2

High-dose steroids (≥20 mg prednisolone daily) significantly increase risk of respiratory tract infection, opportunistic infection, and septicemia, according to the European Crohn's and Colitis Organisation 7, 3, 4, 5
Patients on ≥20 mg daily should observe enhanced precautions, as recommended by the Centers for Disease Control and Prevention 7, 3, 4, 5
Add PCP prophylaxis if >3 weeks of immunosuppression expected at doses >30 mg prednisone equivalent daily, according to the Infectious Diseases Society of America 6
Start proton pump inhibitor for GI prophylaxis during corticosteroid use, as suggested by the American College of Gastroenterology 6

Budesonide MMX 9 mg daily for 8 weeks for flaring ulcerative colitis, according to the National Institute for Health and Care Excellence 7, 3, 4, 5
Beclometasone 5 mg daily for 4 weeks for flaring ulcerative colitis, as recommended by the European Crohn's and Colitis Organisation 7, 3, 4, 5
Budesonide (Entocort, Budenofalk) 9 mg daily for 8 weeks for active small bowel and ileocecal Crohn's disease, according to the American Gastroenterological Association 7, 3, 4, 5

The ultimate goal is complete withdrawal of steroids, as they have no role in maintenance therapy for IBD, according to the American College of Gastroenterology 1, 2
A decisive treatment approach with a clear withdrawal strategy should be communicated to patients from the outset, as recommended by the European Crohn's and Colitis Organisation 1, 2